Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients
about
Glycemic variability and glycemic control in the acutely ill cardiac patientSensitivity of Traditional and Risk-Based Glycemic Variability Measures to the Effect of Glucose-Lowering Treatment in Type 2 Diabetes MellitusItalian contributions to the development of continuous glucose monitoring sensors for diabetes management.Visit-to-visit glycemic variability is a strong predictor of chronic obstructive pulmonary disease in patients with type 2 diabetes mellitus: Competing risk analysis using a national cohort from the Taiwan diabetes study.Glycemic variability and outcome in critically ill.Relationship between autonomic nervous system function and continuous interstitial glucose measurement in patients with type 2 diabetes.Association between impaired cardiovascular autonomic function and hypoglycemia in patients with type 1 diabetes.Lower blood glucose and variability are associated with earlier recovery from renal injury caused by episodic urinary tract infection in advanced type 2 diabetic chronic kidney disease.Glycemic variability and oxidative stress: a link between diabetes and cardiovascular disease?Effects of vildagliptin compared with glibenclamide on glucose variability after a submaximal exercise test in patients with type 2 diabetes: study protocol for a randomized controlled trial, DIABEX VILDA.Aerobic and combined exercise sessions reduce glucose variability in type 2 diabetes: crossover randomized trial.Parental history of type 2 diabetes, TCF7L2 variant and lower insulin secretion are associated with incident hypertension. Data from the DESIR and RISC cohorts.Blood Pressure Variability and Cognitive Function in the Elderly.Cerebral hemodynamics and systemic endothelial function are already impaired in well-controlled type 2 diabetic patients, with short-term disease.Glycemic variability in nondiabetic morbidly obese persons: results of an observational study and review of the literatureThe association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes.Blood pressure regulation in diabetic patients with and without peripheral neuropathy.Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot StudySelf-reported discrimination, diabetes distress, and continuous blood glucose in women with type 2 diabetesReduction of serum FABP4 level by sitagliptin, a DPP-4 inhibitor, in patients with type 2 diabetes mellitus.Associations between body fat variability and later onset of cardiovascular disease risk factorsAssociations among glycemic excursions, glycated hemoglobin and high-sensitivity C-reactive protein in patients with poorly controlled type 2 diabetes mellitus.Relationship between fluctuations in glucose levels measured by continuous glucose monitoring and vascular endothelial dysfunction in type 2 diabetes mellitus.Diabetic autonomic imbalance and glycemic variability.Heart rate variability is associated with interstitial glucose fluctuations in type 2 diabetic women treated with insulinGlucose variability and inner retinal sensory neuropathy in persons with type 1 diabetes mellitus.Effect of eating vegetables before carbohydrates on glucose excursions in patients with type 2 diabetesRetinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability.Potential anti-atherosclerotic effects of dipeptidyl peptidase-4 inhibitors in type 2 diabetes mellitus.Interrupting prolonged sitting in type 2 diabetes: nocturnal persistence of improved glycaemic control.Ambulant 24-h glucose rhythms mark calendar and biological age in apparently healthy individuals.Hypoglycemia and risk of vascular events and mortality: a systematic review and meta-analysis.HbA1c variability is associated with increased mortality and earlier hospital admission in people with Type 1 diabetes.Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes.Glycemic variability: both sides of the story.The need for identifying standardized indices for measuring glucose variability.International Forum for the Advancement of Diabetes Research and Care, April 29-30, 2011, Athens, Greece.Comment on: Kromhout et al. n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes. Diabetes Care 2011;34:2515-2520.Identifying the independent effect of HbA1c variability on adverse health outcomes in patients with Type 2 diabetes.The effects of 2 weeks of interval vs continuous walking training on glycaemic control and whole-body oxidative stress in individuals with type 2 diabetes: a controlled, randomised, crossover trial.
P2860
Q26821994-6D918721-71DA-4D1D-8A0F-C37BF4C914BAQ30279181-B71D41D7-C949-4E81-B06D-D897178D536EQ30458979-78A237E5-0631-401D-9D73-41F1410EB3E3Q33657819-71B0BA76-7263-43F5-9D84-34F8DF88E285Q33719438-B99FEC97-22CC-4D41-9F60-55AC19487723Q34064565-DF51CB16-2C9E-4ED2-A7C6-1C055A723456Q34073479-26939AB8-C97D-415C-8701-294FC7A646B7Q34258750-397C34D1-FB9B-44A9-8BA9-6836C7D53CBEQ34486820-A6A954DF-5E85-4A51-BB2F-3988E03A7368Q34517324-2C1AA616-4394-4CD9-ACC4-CF80CCCF2220Q34639013-B308D330-F5F4-4000-A016-CE248E2467E4Q34940230-287857BB-524C-49A1-B514-5B3F591A29B9Q35043147-2AF53E81-41A4-4E9F-9961-E7B0511A768AQ35082425-46270ECE-8E9A-40C4-8A82-E2510E5E3A60Q35682645-C1B08E37-728E-488A-9643-733147F52893Q35711866-E194F2AB-9D64-4312-86F6-77416F487B54Q35850273-7B4E596C-A975-498B-8123-EB2C59FCBB5CQ35931098-864525EC-4EF0-494A-827C-698003852D1EQ35992884-BA257F7D-8C8C-4A9D-8908-E07E18E19C9EQ36307279-DCB55D4A-9732-4636-841D-89FE3CC04887Q36331973-F714B6D4-2586-4F26-8DEE-CFA84D856BA6Q36335525-E842A978-E706-43B5-823A-ABAAFA618C58Q36568360-3822CFFB-B16A-4EB7-804E-7B52DED8C0D8Q36605744-EDE4CB04-2C51-4803-88B3-46A9416C9759Q36689873-EA5CC9B1-C8B7-426C-8F85-266EC94AA32DQ37000730-89F0FB2A-463A-4035-9ABC-F840A3ACEF51Q37440339-35388D36-D0D1-412E-ABDC-4CDA9A93B507Q37742818-40482613-380C-452B-833C-A6595BF9A6C5Q38175855-BD52A608-4026-464C-BE71-50F885FC2EF5Q38375023-2534D115-176C-4DE6-91E1-1045D02D1648Q38428332-ADFB1380-076C-4719-9FC4-0B8778C43497Q38572028-8E3BDA1C-2719-432B-813C-686792F68321Q38612071-FB949A47-9DC5-4E53-9A7B-9E387CF6D10CQ40232094-00ABCD9D-1AF2-4A4E-9073-B605F5C0A4B2Q41946046-E88AE3CB-E742-4525-B3F9-A0B612B87A2DQ42555071-F089DA8E-56C7-4704-B9E8-E08A15B94078Q42730182-9F78EB04-64E6-4527-835E-F66830015142Q43179563-FF1D070C-1EC6-4B9C-AD60-40CAB018A09AQ48052763-29E01810-3C8C-400A-9D9A-5D8307A88D78Q48164984-FEF1A24F-B41E-42F3-91A9-75D965FDD344
P2860
Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Impact of glycemic and blood p ...... es in type 2 diabetic patients
@ast
Impact of glycemic and blood p ...... es in type 2 diabetic patients
@en
type
label
Impact of glycemic and blood p ...... es in type 2 diabetic patients
@ast
Impact of glycemic and blood p ...... es in type 2 diabetic patients
@en
prefLabel
Impact of glycemic and blood p ...... es in type 2 diabetic patients
@ast
Impact of glycemic and blood p ...... es in type 2 diabetic patients
@en
P2093
P2860
P356
P1433
P1476
Impact of glycemic and blood p ...... es in type 2 diabetic patients
@en
P2093
Alessandra Di Flaviani
Carlo Peraldo
Fabiana Picconi
Fabrizio Farina
Fabrizio Sgreccia
Gaetano Frajese
Ilaria Giordani
Ilaria Malandrucco
Paola Di Stefano
Paola Maggio
P2860
P304
P356
10.2337/DC11-0034
P407
P577
2011-05-24T00:00:00Z